Cytogens linguals — bioregulators based on synthesized peptides in sublingual form of application

The new line of peptide bioregulators developed by the St. Petersburg Institute of Bioregulation and Gerontology includes peptides of the Cytogen class (6 preparations) in sublingual monopeptides and the only complex preparation in the series of lingual cytogens based on synthesized peptides (Visilingval® lingval).

In them, the daily dose is reduced by 2 times in comparison with encapsulated monopreparations of the “Cytogen” class. This is due to the new form of application of bioregulators, since it provides a higher bioavailability of the preparation and the speed of its action. Thus, the new generation of preparations has a significant plus — the ability to more accurately select an individual dose of the preparation and a mild effect on the problem.